Literature DB >> 15147311

Short-term exposure to constant light promotes strong circadian phase-resetting responses to nonphotic stimuli in Syrian hamsters.

Megan E Knoch1, Sharon M H Gobes, Ivanda Pavlovska, Cathy Su, Ralph E Mistlberger, J David Glass.   

Abstract

Behavioral (nonphotic) stimuli can shift circadian rhythms by serotonin (5-HT) and/or neuropeptide Y (NPY) inputs to the suprachiasmatic nucleus (SCN) circadian clock. Based on the idea that behavioral phase resetting is modulated by endogenous changes in postsynaptic sensitivity to such transmitters, hamsters were exposed to constant light (LL; approximately 250 lx) for 1-3 days, which suppresses locomotor activity and eliminates the daily rhythm of SCN 5-HT release measured by microdialysis. Groups subjected to brief LL or maintained under a light/dark cycle (LD) received phase-resetting treatments with the 5-HT(1A,7) agonist (+/-)-2-dipropyl-amino-8-hydroxyl-1,2,3,4-tetrahydronapthalene (8-OH-DPAT) or sleep deprivation (SD). Animals were released to constant darkness at the start of the treatments. Phase advances to 8-OH-DPAT and SD during the day were 11 and 3 h for LL vs. 2 and 1 h for LD, respectively. Phase delays during the night were -12 and -5 h for LL vs. no responses for LD, respectively. Phase-transition curves for both LL treatments had slopes approximating 0, indicative of Type 0 phase resetting. For all treatments, the degree of locomotor suppression by LL was not correlated with the phase shift magnitude. Re-establishing locomotor activity by overnight food deprivation did not prevent potentiated shifting to SD. However, re-establishing peak extracellular 5-HT levels by intra-SCN 5-HT reverse microdialysis perfusion in LL did significantly reduce potentiated 8-OH-DPAT phase advances. Constant light also enhanced intra-SCN NPY-induced phase advances during the day (6 vs. 2 h for LD). These results suggest that LL promotes Type 0 phase resetting by supersensitizing 5-HT and/or NPY postsynaptic responses and possibly by attenuating the amplitude of the circadian pacemaker, thus enhancing circadian clock resetting nonspecifically.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147311     DOI: 10.1111/j.0953-816X.2004.03371.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Brief constant light accelerates serotonergic re-entrainment to large shifts of the daily light/dark cycle.

Authors:  G Kaur; R Thind; J D Glass
Journal:  Neuroscience       Date:  2009-02-13       Impact factor: 3.590

2.  Environmental modulation of alcohol intake in hamsters: effects of wheel running and constant light exposure.

Authors:  Steven B Hammer; Christina L Ruby; Allison J Brager; Rebecca A Prosser; John David Glass
Journal:  Alcohol Clin Exp Res       Date:  2010-06-21       Impact factor: 3.455

3.  Acute ethanol disrupts photic and serotonergic circadian clock phase-resetting in the mouse.

Authors:  Allison J Brager; Christina L Ruby; Rebecca A Prosser; J David Glass
Journal:  Alcohol Clin Exp Res       Date:  2011-04-04       Impact factor: 3.455

4.  The mPer2 clock gene modulates cocaine actions in the mouse circadian system.

Authors:  Allison J Brager; Adam C Stowie; Rebecca A Prosser; J David Glass
Journal:  Behav Brain Res       Date:  2013-01-17       Impact factor: 3.332

5.  Acute ethanol modulates glutamatergic and serotonergic phase shifts of the mouse circadian clock in vitro.

Authors:  R A Prosser; C A Mangrum; J D Glass
Journal:  Neuroscience       Date:  2008-01-29       Impact factor: 3.590

6.  Chronic ethanol intake modulates photic and non-photic circadian phase responses in the Syrian hamster.

Authors:  Joseph A Seggio; Ryan W Logan; Alan M Rosenwasser
Journal:  Pharmacol Biochem Behav       Date:  2007-05-10       Impact factor: 3.533

7.  Extraordinary behavioral entrainment following circadian rhythm bifurcation in mice.

Authors:  Elizabeth M Harrison; Thijs J Walbeek; Jonathan Sun; Jeremy Johnson; Qays Poonawala; Michael R Gorman
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.